| [1] |
LI Mingying, ZHANG Xiaoxia, SUN Xiaoli, ZHAO Yan, HE Miao, LI Yanling, DUAN Wei, YANG Ou.
Effect of Sugammadex on Recovery of Patients after Laparoscopic Total Pelvic Floor Reconstruction
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(8): 896-901.
|
| [2] |
MEI Haonan, ZHANG Ziyi, WANG Yuxi, WANG Hui, GUO Yu.
Developmental Toxicity and Mechanisms of Acetaminophen Exposure during Pregnancy
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 702-707.
|
| [3] |
LAN Xiaoqian, GUO Wei.
Trough Steady-State Concentration/Dose Ratio and Contributors to Adverse Drug Reactions of Sulpiride
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 420-423.
|
| [4] |
LUO Wen, WU Jing, HE Dake, YANG Rui.
One Case of Dermatitis Medicamentosa in a Paediatric Epilepsy Patient Caused by Lacosamide Oral Solution
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(4): 452-455.
|
| [5] |
ZOU Yuanlei, XIA Qingrong, LIANG Jun, HE Kongliang, MO Daming, WU Wenning.
Words of Warning and Preventive Measures in Labels of Antidepressants
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 329-333.
|
| [6] |
ZHOU Kun, MA Liang, LI Zhaofeng, CAO Bing, GU Hongwei, LIU Qian.
Usage of Nerve-Calming Chinese Herbal Patent Medicines in a Mental Health Center
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 211-216.
|
| [7] |
DAI Biao, CAO Yin, SUN Yanhong, ZHANG Yuanyuan, XIA Qingrong.
808 Cases of Adverse Drug Reaction Caused by Antipsychotic Drugs
[J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 99-103.
|
| [8] |
ZHANG Longying, LOU Lifeng, YOU Qian, WEI Yubing, CAI Yan, LI Bin.
Medications and Adverse Reaction in Children and Adolescents with Depressive Disorders
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1419-1424.
|
| [9] |
LUO Jianchao, YANG Rong, FU Qiong, LI Jixian.
Correlations between Serum Concentrations of Risperidone and Serum Trace Elements in Patients with Schizophrenia
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1276-1279.
|
| [10] |
LIU Xiaohui, ZHOU Li, ZHAO Yiming, LI Ying, WU Xirong, WANG Xiaoling, XU Baoping.
Reminders of Addiction in Drug Labels of Dextromethorphan
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1299-1302.
|
| [11] |
XU Zeao, JIANG Haiyan, FAN Xiaoyu, LI Wanfang, BAO Jie, XU Cheng, JIN Hongtao.
Research progress in compound drugs for anti-neurodegenerative diseases
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(9): 967-972.
|
| [12] |
ZHENG Haiyun, ZHANG Wen, WANG Shaonan, ZHAO Haiyu, DU Shouying.
Anti-fatigue effects and mechanism of ginseng combined with caffeine in rats
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 863-870.
|
| [13] |
ZHANG Qian, YUN Yuan, HE Lian.
Pharmaceutical care of hyperprolactinemia in a patient induced by risperidone
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 936-938.
|
| [14] |
ZHANG Xian, QU Jianchang, ZHAO Qiang, XU Xin, MA Rui.
One case of hyponatremia induced by venlafaxine hydrochloride sustained-release capsules
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 819-821.
|
| [15] |
LIU Yang, FAN Zheng, WANG Honglei, YANG Ying, GUO Qi, CHANG Xinyu, HAN Lijuan, LI Wenzhe, WU Jiankun.
Therapeutic effect of Jingzhui Kangfu pills against osteoarthritis induced by proteoglycan in mice
[J]. Chinese Journal of Pharmacovigilance, 2024, 21(6): 651-654.
|
